Cutaneous Vasculitis Update: Diagnostic Criteria, Classification, Epidemiology, Etiology, Pathogenesis, Evaluation and Prognosis
The DOI matches its Crossref record; 111 of the 111 references it cites were found in a registry or an index.
Abstract
Vasculitis, inflammation of the vessel wall, can result in mural destruction with hemorrhage, aneurysm formation, and infarction, or intimal-medial hyperplasia and subsequent stenosis leading to tissue ischemia. The skin, in part due to its large vascular bed, exposure to cold temperatures, and frequent presence of stasis, is involved in many distinct as well as un-named vasculitic syndromes that vary from localized and self-limited to generalized and life-threatening with multi-organ disease. To exclude mimics of vasculitis, diagnosis of cutaneous vasculitis requires biopsy confirmation where its acute signs (fibrinoid necrosis), chronic signs (endarteritis obliterans), or past signs (acellular scar of healed arteritis) must be recognized and presence of extravascular findings such as patterned fibrosis or collagenolytic granulomas noted. Although vasculitis can be classified by etiology, many cases have no identifiable cause, and a single etiologic agent can elicit several distinct clinicopathologic expressions of vasculitis. Therefore, the classification of cutaneous vasculitis is best approached morphologically by determining vessel size and principal inflammatory response. These histologic patterns roughly correlate with pathogenic mechanisms that, when coupled with direct immunofluorescent examination, anti-neutrophil cytoplasmic antibody (ANCA) status, and findings from work-up for systemic disease, allow for specific diagnosis, and ultimately, more effective therapy. Herein, we review cutaneous vasculitis focusing on diagnostic criteria, classification, epidemiology, etiology, pathogenesis, and evaluation of the cutaneous vasculitis patient.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The american college of rheumatology 1990 criteria for the classification of fibromyalgia
Wolfe, F., Smythe, H. A., Yunus, M. B., Bennett, R. M., Bombardier, C., Goldenberg, D. L., Tugwell, P., Campbell, S. M., Abeles, M., Clark, P., et al. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330203 · Cited by 9,563
Nomenclature of Systemic Vasculitides
Jennette, J. C., Falk, R. J., Andrassy, K., Bacon, P. A., Churg, J., Gross, W. L., Hagen, E. C., Hoffman, G. S., Hunder, G. G., Kallenberg, C. G. M., et al. (1994) · Arthritis & Rheumatism · doi:10.1002/art.1780370206 · Cited by 3,845 · cited 1×
“Most of the classification criteria derived from groups such as the CHCC or the ACR were not originally developed as diagnostic criteria for individual patients (particularly those with early disease), but for comparisons of groups of patients.(30,31) Table 1 lists the diagnostic criteria for primary vasculitis promul…”
MethodThe Banff 97 working classification of renal allograft pathology
Racusen, L. C., Solez, K., Colvin, R. B., Bonsib, S. M., Castro, M. C., Cavallo, T., Croker, B. P., Demetris, A. J., Drachenberg, C. B., Fogo, A. B., et al. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00299.x · Cited by 3,033
The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis
Hunder, G. G., Bloch, D. A., Michel, B. A., Stevens, M. B., Arend, W. P., Calabrese, L. H., Edworthy, S. M., Fauci, A. S., Leavitt, R. Y., Lie, J. T., et al. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330810 · Cited by 2,539
Chronic graft-versus-host syndrome in man
Shulman, H. M., Sullivan, K. M., Weiden, P. L., McDonald, G. B., Striker, G. E., Sale, G. E., Hackman, R., Tsoi, M.-S., Storb, R., & Donnall Thomas, E. (1980) · The American Journal of Medicine · doi:10.1016/0002-9343(80)90380-0 · Cited by 2,406
The American College of Rheumatology 1990 criteria for the classification of takayasu arteritis
Arend, W. P., Michel, B. A., Bloch, D. A., Hunder, G. G., Calabrese, L. H., Edworthy, S. M., Fauci, A. S., Leavitt, R. Y., Lie, J. T., Lightfoot, R. W., et al. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330811 · Cited by 2,267
Masi, A. T., Hunder, G. G., Lie, J. T., Michel, B. A., Bloch, D. A., Arend, W. P., Calabrese, L. H., Edworthy, S. M., Fauci, A. S., Leavitt, R. Y., et al. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330806 · Cited by 2,215
Leavitt, R. Y., Fauci, A. S., Bloch, D. A., Michel, B. A., Hunder, G. G., Arend, W. P., Calabrese, L. H., Fries, J. F., Lie, J. T., Lightfoot, R. W., et al. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330807 · Cited by 1,947
Clinical Aspects of Immunology.
(1969) · Annals of Internal Medicine · doi:10.7326/0003-4819-71-1-229_2 · Cited by 1,527 · cited 2×
“These mechanisms can be classified into 4 basic types of hypersensitivity reactions per Coombs and Gell.130 Specifically, vasculitis can be pathogenically termed (1) allergic vasculitis, (2) antibodymediated vasculitis, (3) immune complex (IC)-mediated vasculitis, and (4) T-cell mediated hypersensitivity vasculitis.”
BackgroundJennette, J. C., & Falk, R. J. (1997) · New England Journal of Medicine · doi:10.1056/nejm199711203372106 · Cited by 1,323
The American college of rheumatology 1990 criteria for the classification of polyarteritis nodosa
Lightfoot, R. W., Michel, B. A., Bloch, D. A., Hunder, G. G., Zvaifler, N. J., McShane, D. J., Arend, W. P., Calabrese, L. H., Leavitt, R. Y., Lie, J. T., et al. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330805 · Cited by 1,076
Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis.
Luqmani, R. A., BACON, P. A., Moots, R. J., Janssen, B. A., Pall, A. A., Emery, P., Savage, C. O. S., & Adu, D. (1994) · PubMed · Cited by 1,056
Xiao, H., Heeringa, P., Hu, P., Liu, Z., Zhao, M., Aratani, Y., Maeda, N., Falk, R. J., & Jennette, J. C. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15918 · Cited by 1,005 · cited 1×
“between ANCA and the development of glomerulonephritis and vasculitis has been demonstrated in an experimental model: passive transfer of ANCA was sufficient to induce disease in mice.(150) Lymphopenia and persistent activation of CD4 T cells (CD25+) may play a role in the development of ANCA and ANCA-associated vascu…”
BackgroundCytokines and cytokine inhibitors or antagonists in rheumatoid arthritis
Arend, W. P., & Dayer, J. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330302 · Cited by 949
Xiao, H., Heeringa, P., Hu, P., Liu, Z., Zhao, M., Aratani, Y., Maeda, N., Falk, R. J., & Jennette, J. C. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215918 · Cited by 919
Mills, J. A., Michel, B. A., Bloch, D. A., Calabrese, L. H., Hunder, G. G., Arend, W. P., Edworthy, S. M., Fauci, A. S., Leavitt, R. Y., Lie, J. T., et al. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330809 · Cited by 857
Hunder, G. G., Arend, W. P., Bloch, D. A., Calabrese, L. H., Fauci, A. S., Fries, J. F., Leavitt, R. Y., Lie, J. T., Lightfoot, R. W., Masi, A. T., et al. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330802 · Cited by 687
The American College of Rheumatology 1990 criteria for the classification of vasculitis: Summary
Fries, J. F., Hunder, G. G., Bloch, D. A., Michel, B. A., Arend, W. P., Calabrese, L. H., Fauci, A. S., Leavitt, R. Y., Lie, J. T., Lightfoot, R. W., et al. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330812 · Cited by 589
Fernández, H. N., Henson, P. M., Otani, A., & Hugli, T. E. (1978) · PubMed · Cited by 567
Mahr, A., Guillevin, L., Poissonnet, M., & Aymé, S. (2004) · Arthritis Care & Research · doi:10.1002/art.20077 · Cited by 550 · cited 1×
“Environmental factors such as silica, solvents, allergies, and farm work account for some of the differences in the incidence of the vasculitides among individuals.(94,95) Non-whites appear to be protected against GCA.”
BackgroundChemotactic Response to Human C3a and C5a Anaphylatoxins
Fernandez, H. N., Henson, P. M., Otani, A., & Hugli, T. E. (1978) · The Journal of Immunology · doi:10.4049/jimmunol.120.1.109 · Cited by 443
Boomsma, M. M., Stegeman, C. A., Van Der Leij, M. J., Oost, W., Hermans, J., Kallenberg, C. G. M., Limburg, P. C., & Tervaert, J. W. C. (2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200009)43:9<2025::aid-anr13>3.0.co;2-o · Cited by 434
Libby, P., & Pober, J. S. (2001) · Immunity · doi:10.1016/s1074-7613(01)00119-4 · Cited by 375
Booth, A., Harper, L., Hammad, T., Bacon, P., Griffith, M., Levy, J., Savage, C., Pusey, C., & Jayne, D. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000114554.67106.28 · Cited by 359 · cited 1×
“Anti-TNF-alpha therapy can reverse this endothelial dysfunction highlighting its role in the pathogenesis of vasculitis and its accompanying diffuse endothelial dysfunction.(122,123) Lastly, inflammationpromoted angiogenesis or neovascularization found in some lesions of both cutaneous and systemic vasculitides may re…”
BackgroundRao, J. K., Allen, N. B., & Pincus, T. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-129-5-199809010-00001 · Cited by 338 · cited 1×
“Applying ACR criteria for WG, PAN, giant cell arteritis (GCA), and hypersensitivity vasculitis to patients suspected of having vasculitis reveals a poor positive predictive value ranging from 17% to 29%.(29) In that study by Rao et al,(29) the clinical findings of palpable purpura, neuropathy, and microscopic hematuri…”
BackgroundFc Receptors Initiate the Arthus Reaction: Redefining the Inflammatory Cascade
Sylvestre, D. L., & Ravetch, J. V. (1994) · Science · doi:10.1126/science.8066448 · Cited by 321
Bloch, D. A., Michel, B. A., Hunder, G. G., McShane, D. J., Arend, W. P., Calabrese, L. H., Edworthy, S. M., Fauci, A. S., Fries, J. F., Leavitt, R. Y., et al. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330803 · Cited by 300
Hernandez-Rodriguez, J. (2003) · Rheumatology · doi:10.1093/rheumatology/keh058 · Cited by 295
Biedermann, B. C., Sahner, S., Gregor, M., Tsakiris, D. A., Jeanneret, C., Pober, J. S., & Gratwohl, A. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08907-9 · Cited by 253
Systemic Vasculitis in Adults in Northwestern Spain, 1988-1997: Clinical and Epidemiologic Aspects
Gonzalez-Gay, M. A., & García-Porrúa, C. (1999) · Medicine · doi:10.1097/00005792-199909000-00002 · Cited by 243
Primary systemic vasculitis: clinical features and mortality
Lane, S. E., Watts, R. A., Shepstone, L., & Scott, D. G. I. (2005) · QJM · doi:10.1093/qjmed/hci015 · Cited by 243
Cutaneous small-vessel vasculitis
Lotti, T., Ghersetich, I., Comacchi, C., & Jorizzo, J. L. (1998) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(98)70039-8 · Cited by 233
Gonzalez‐Gay, M. A., Garcia‐Porrua, C., Guerrero, J., Rodriguez‐Ledo, P., & Llorca, J. (2003) · Arthritis Care & Research · doi:10.1002/art.11115 · Cited by 229 · cited 1×
“The variation in the incidences of vasculitis between different regions of the world studied likely reflects both population and environmental differences.(92,93,105) In Europe, the incidence of PSVappears to be increasing with age where WG appears to be more common at high latitudes and MPA more common at lower latit…”
BackgroundEPIDEMIOLOGY OF THE VASCULITIDES
González-Gay, M. A., & García-Porrúa, C. (2001) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(05)70232-5 · Cited by 227
Inflammation and arterial stiffness in systemic vasculitis: A model of vascular inflammation
Booth, A. D., Wallace, S., McEniery, C. M., Yasmin, Brown, J., Jayne, D. R. W., & Wilkinson, I. B. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20002 · Cited by 225 · cited 1×
“In fact, systemic vasculitis has been found to be associated with arterial stiffness, a marker of diffuse endothelial dysfunction, which directly correlates with the degree of inflammation and disease activity.(121) Anti-TNF-alpha therapy can reverse this endothelial dysfunction highlighting its role in the pathogenes…”
BackgroundWeck, K. E., Dal Canto, A. J., Gould, J. D., O'Guin, A. K., Roth, K. A., Saffitz, J. E., Speck, S. H., & Virgin, H. W. (1997) · Nature Medicine · doi:10.1038/nm1297-1346 · Cited by 223
Daoud, M. S., Gibson, L. E., DeRemee, R. A., Specks, U., el-Azhary, R. A., & Daniel Su, W. P. (1994) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(94)70224-1 · Cited by 213
Are environmental factors important in primary systemic vasculitis?: A case–control study
Lane, S. E., Watts, R. A., Bentham, G., Innes, N. J., & Scott, D. G. I. (2003) · Arthritis & Rheumatism · doi:10.1002/art.10830 · Cited by 209 · cited 1×
“Environmental factors such as silica, solvents, allergies, and farm work account for some of the differences in the incidence of the vasculitides among individuals.(94,95) Non-whites appear to be protected against GCA.”
BackgroundFiorentino, D. F. (2003) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2003.212 · Cited by 207
Cutaneous vasculitis: a review
CROWSON, A. N., Mihm, M. C., & MAGRO, C. M. J. (2003) · Journal of Cutaneous Pathology · doi:10.1034/j.1600-0560.2003.00033.x · Cited by 192
Höpken, U. E., Lu, B., Gerard, N. P., & Gerard, C. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.5.749 · Cited by 183
Endothelial and platelet microparticles in vasculitis of the young
Brogan, P. A., Shah, V., Brachet, C., Harnden, A., Mant, D., Klein, N., & Dillon, M. J. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20199 · Cited by 176
Recent Advances in the Diagnosis of Churg-Strauss Syndrome
Churg, A. (2001) · Modern Pathology · doi:10.1038/modpathol.3880475 · Cited by 176 · cited 1×
“19).(145) This is similar to the histology of eosinophilic vasculitis, a recently described entity that is associated with CTD, hypocomplementemia, and decreased tissue mast cells.”
ResultCUTANEOUS AND VISCERAL SYNDROMES OF NECROTIZING OR “ALLERGIC” ANGIITIS: A STUDY OF 38 CASES
WINKELMANN, R. K., & DITTO, W. B. (1964) · Medicine · doi:10.1097/00005792-196401000-00003 · Cited by 174 · cited 1×
“For patients with cutaneous vasculitis secondary to systemic disease, the interval between the onset of symptoms and signs of the systemic disease can vary from days to years, mean of 6 months, before the onset of cutaneous vasculitis.(73) Three patterns of disease evolution occur in cutaneous vasculitis: (1) single a…”
BackgroundBlanco, R., Martinez-Taboada, V. M., Rodriguez-Valverde, V., & Garcia-Fuentes, M. (1998) · Medicine · doi:10.1097/00005792-199811000-00007 · Cited by 172
Infliximab Improves Endothelial Dysfunction in Systemic Vasculitis: A Model of Vascular Inflammation
Booth, A. D., Jayne, D. R. W., Kharbanda, R. K., McEniery, C. M., Mackenzie, I. S., Brown, J., & Wilkinson, I. B. (2004) · Circulation · doi:10.1161/01.cir.0000124720.18538.dd · Cited by 165 · cited 1×
“Anti-TNF-alpha therapy can reverse this endothelial dysfunction highlighting its role in the pathogenesis of vasculitis and its accompanying diffuse endothelial dysfunction.(122,123) Lastly, inflammationpromoted angiogenesis or neovascularization found in some lesions of both cutaneous and systemic vasculitides may re…”
BackgroundGonzález-Gay, M. A., Amoli, M. M., Garcia-Porrua, C., & Ollier, W. E. R. (2003) · Seminars in Arthritis and Rheumatism · doi:10.1053/sarh.2002.50025 · Cited by 160 · cited 6×
“Pathologically, it occurs in pulmonary hypertension, atherosclerosis, after angioplasty, in vein grafts, in transplant rejection, in thrombotic disorders, PAN, and GCA.”
BackgroundInfluentialImmune complexes in human diseases: a review.
Theofilopoulos, A. N., & Dixon, F. J. (1980) · PubMed Central · Cited by 159
Sørensen, S. F., Slot, O., Tvede, N., & Petersen, J. (2000) · Annals of the Rheumatic Diseases · doi:10.1136/ard.59.6.478 · Cited by 154 · cited 3×
“However, in many cases, specific clinical entities do not always correlate exactly with mechanisms and any one patient may have a constellation of morphologic signs that overlaps with another clinical entity thus preventing confident clinical diagnosis.(8,9) A definitive diagnosis of vasculitis requires histologic con…”
BackgroundMethodRaza, K., Thambyrajah, J., Townend, J. N., Exley, A. R., Hortas, C., Filer, A., Carruthers, D. M., & Bacon, P. A. (2000) · Circulation · doi:10.1161/01.cir.102.13.1470 · Cited by 152
Cutaneous manifestations of Churg-Strauss syndrome: A clinicopathologic correlation
Davis, M. D. P., Daoud, M. S., McEvoy, M. T., & Su, W. P. D. (1997) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(97)80125-9 · Cited by 151
Accelerated atherosclerosis in patients with Wegener's granulomatosis
de Leeuw, K., Sanders, J.-S., Stegeman, C. A., Smit, A. J., Kallenberg, C. G., & Bijl, M. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.029033 · Cited by 151 · cited 1×
“Of note, the persistence of inflammation and endothelial dysfunction in systemic vasculitis appears to have long-term consequences, leading to the acceleration of atherosclerosis and premature ischemic heart disease.(120,124,125)”
BackgroundTwo Distinct Cellular Patterns In Cutaneous Necrotizing Angitis
Soter, N. A., Mihm, M. C., Gigli, I., Dvorak, H. F., & Austen, K. F. (1976) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12482901 · Cited by 150
Guillevin, L., Lhote, F., Amouroux, J., Gherardi, R., Callard, P., & Casassus, P. (1996) · British journal of rheumatology · doi:10.1093/rheumatology/35.10.958 · Cited by 139 · cited 1×
“However, in many cases, specific clinical entities do not always correlate exactly with mechanisms and any one patient may have a constellation of morphologic signs that overlaps with another clinical entity thus preventing confident clinical diagnosis.(8,9) A definitive diagnosis of vasculitis requires histologic con…”
BackgroundTemporal artery biopsy: A diagnostic tool for systemic necrotizing vasculitis
G�n�reau, T., Lortholary, O., Ma, P., Michon-Pasturel, U., Ponge, T., de Wazières, B., Liozon, É., Pin�de, L., HACHULLA, E., Roblot, P., et al. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199912)42:12<2674::aid-anr25>3.0.co;2-a · Cited by 138
Clinical Features and Outcome of 95 Patients With Hypersensitivity Vasculitis
Martínez-Taboada, V. M., Ricardo Blanco, M., García‐Fuentes, M., & Rodríguez-Valverde, V. (1997) · The American Journal of Medicine · doi:10.1016/s0002-9343(96)00405-6 · Cited by 138 · cited 3×
“7 years.(33,91) The onset of vasculitis after exposure to a trigger such as a drug or infection is 7 to 10 days.”
BackgroundMethodFiler, A. D., Gardner-Medwin, J. M., Thambyrajah, J., Raza, K., Carruthers, D. M., Stevens, R. J., Liu, L., Lowe, S. E., Townend, J., & Bacon, P. A. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.62.2.162 · Cited by 132 · cited 1×
“In turn, this localized vessel wall inflammation can have systemic effects by eliciting diffuse endothelial dysfunction in distant vascular beds via release of secondary mediators such as TNF and CRP directly into the blood stream.(119,120) In fact, systemic vasculitis has been found to be associated with arterial sti…”
BackgroundThe epidemiology of giant cell arteritis
Liu, N. H., LABREE, L. D., Feldon, S. E., & Rao, N. A. (2001) · Ophthalmology · doi:10.1016/s0161-6420(01)00574-7 · Cited by 119 · cited 6×
“Pathologically, it occurs in pulmonary hypertension, atherosclerosis, after angioplasty, in vein grafts, in transplant rejection, in thrombotic disorders, PAN, and GCA.”
BackgroundInfluentialA Codominant Role of FcγRI/III and C5aR in the Reverse Arthus Reaction
Baumann, U., Köhl, J., Tschernig, T., Schwerter-Strumpf, K., Verbeek, J. S., Schmidt, R. E., & Gessner, J. E. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.2.1065 · Cited by 116
Garcı́a-Porrúa, C., & González-Gay, M. Á. (1999) · Seminars in Arthritis and Rheumatism · doi:10.1016/s0049-0172(99)80006-7 · Cited by 113
Immunopathways in giant cell arteritis and polymyalgia rheumatica
Weyand, C. M., Ma-Krupa, W., & Goronzy, J. J. (2003) · Autoimmunity Reviews · doi:10.1016/s1568-9972(03)00064-8 · Cited by 112
Primary vasculitis in a Norwegian community hospital: A retrospective study
Haugeberg, G., Bie, R. B., Bendvold, A. N., Larsen, A. S., & Johnsen, V. (1998) · Clinical Rheumatology · doi:10.1007/bf01450893 · Cited by 111
Yarwood, J. M., Leung, D. Y. M., & Schlievert, P. M. (2000) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2000.tb09350.x · Cited by 107
Gauthier, V., Mannik, M., & Striker, G. E. (1982) · The Journal of Experimental Medicine · doi:10.1084/jem.156.3.766 · Cited by 106
Peripheral nerve vasculitis: Immune characterization of the vascular lesions
Kissel, J. T., Riethman, J. L., Omerza, J., Rammohan, K. W., & Mendell, J. R. (1989) · Annals of Neurology · doi:10.1002/ana.410250314 · Cited by 103
Augmentation of reverse arthus reaction by mast cells in mice.
Zhang, Y., Ramos, B. F., & Jakschik, B. A. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115385 · Cited by 99
“Essential” cutaneous vasculitis: what every rheumatologist should know about vasculitis of the skin
Stone, J. H., & Nousari, H. C. (2001) · Current Opinion in Rheumatology · doi:10.1097/00002281-200101000-00005 · Cited by 96
Recurrent Cutaneous Necrotizing Eosinophilic Vasculitis: A Novel Eosinophil-Mediated Syndrome
Chen, K. R., Pittelkow, M. R., Su, D., Gleich, J., Newman, W., & Leiferman, K. M. (1994) · Archives of Dermatology · doi:10.1001/archderm.1994.01690090083012 · Cited by 95
Self-citationIncidence of vasculitis in children in the Czech Republic: 2-year prospective epidemiology survey.
Doležalová, P., Telekesová, P., Němcová, D., & Hoza, J. (2004) · PubMed · Cited by 90
Baumann, U., Chouchakova, N., Gewecke, B., Köhl, J., Carroll, M. C., Schmidt, R. E., & Gessner, J. E. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.2.1022 · Cited by 87
Bhan, A. K., Mihm, M. C., & Dvorak, H. F. (1982) · The Journal of Immunology · doi:10.4049/jimmunol.129.4.1578 · Cited by 87
Choy, J. C., Cruz, R. P., Kerjner, A., Geisbrecht, J., Sawchuk, T., Fraser, S. A., Hudig, D., Bleackley, R. C., Jirik, F. R., McManus, B. M., et al. (2005) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2004.00710.x · Cited by 85
Wegener's granulomatosis: A meta-analysis of 349 literary case reports
Bajema, I. M., Hagen, E. C., van der Woude, F. J., & Bruijn, J. A. (1997) · Journal of Laboratory and Clinical Medicine · doi:10.1016/s0022-2143(97)90157-8 · Cited by 82
Cutaneous vasculitis in a defined population--clinical and epidemiological associations.
Watts, R. A., Jolliffe, V., Grattan, C. E., Elliott, J. A., Lockwood, M., & Scott, D. G. I. (1998) · PubMed · Cited by 81
Vasculitis in systemic lupus erythematosis
CALAMIA, K. T., & Balabanova, M. (2004) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2003.12.022 · Cited by 77
Temporal arteritis associated with systemic necrotizing vasculitis.
Hamidou, M. A., Moreau, A., Toquet, C. S., et al. (2003) · PubMed · Cited by 74
Different pathways leading to cutaneous leukocytoclastic vasculitis in mice
Sunderkötter, C. H., Seeliger, S., Schönlau, F., Roth, J., Hallmann, R., Luger, T. A., Sorg, C., & Kolde, G. (2001) · Experimental Dermatology · doi:10.1034/j.1600-0625.2001.100602.x · Cited by 73 · cited 1×
“Loxoscelism) lead to activation of neutrophils and abnormal neutrophil diapedesis, 2 factors that may be common denominators in pathogenesis of neutrophil-associated small vessel vasculitis.(126) Other morphologic patterns of inflammatory vessel injury (vasculitis) exist, which include lymphocytic endarteritis and end…”
BackgroundEndothelial cell dysfunction in systemic vasculitis: new developments and therapeutic prospects
Bacon, P. A. (2004) · Current Opinion in Rheumatology · doi:10.1097/01.bor.0000149084.16639.b0 · Cited by 72 · cited 2×
“In turn, this localized vessel wall inflammation can have systemic effects by eliciting diffuse endothelial dysfunction in distant vascular beds via release of secondary mediators such as TNF and CRP directly into the blood stream.(119,120) In fact, systemic vasculitis has been found to be associated with arterial sti…”
BackgroundFamilial eosinophilic cellulitis, dysmorphic habitus, and mental retardation
Davis, M. D. P., Brown, A. C., Blackston, R. D., Gaughf, C., Peterson, E. A., Gleich, G. J., & Leiferman, K. M. (1998) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(98)70588-2 · Cited by 70
Haas, M., Kraus, E. S., Samaniego, M., Racusen, L. C., Ni, W., & Eustace, J. A. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00254.x · Cited by 69
Abnormalities of CD4+ T cell subpopulations in ANCA-associated vasculitis
Marinaki, S., Neumann, I., Kälsch, A.-I., Grimminger, P., Breedijk, A. J., Birck, R., Schmitt, W. H., Waldherr, R., Yard, B. A., & van der Woude, F. J. (2005) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2005.02731.x · Cited by 68 · cited 1×
“Lymphopenia and persistent activation of CD4 T cells (CD25+) may play a role in the development of ANCA and ANCA-associated vasculitis.(151) ANCA are believed to activate neutrophils and endothelial cells as well as induce accelerated neutrophil apoptosis leading to release of proinflammatory cytokines that maintain a…”
BackgroundEosinophilic vasculitis in connective tissue disease
Chen, K.-R., Su, W. P. D., Pittelkow, M. R., Conn, D. L., George, T. J., & Leiferman, K. M. (1996) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(96)90318-7 · Cited by 66 · cited 1×
“The decrease in mast cells suggests also that mast cell degranulation occurs.(146) Vascular adhesionmolecule 1 (VCAM-1) expression by activated endothelial cells and very late antigen-4 expression by adhering eosinophils distinguishes this form of vasculitis from type III/IC-mediated vasculitis where E-selectin expres…”
BackgroundSelf-citationComplement and Complement Regulatory Proteins as Potential Molecular Targets for Vascular Diseases
Acosta, J. A. T., Qin, X., & Halperin, J. A. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043453441 · Cited by 63
Staphylococcal superantigens and T cell expansions in Wegener's granulomatosis
Popa, E. R., Stegeman, C. A., Bos, N. A., Kallenberg, C. G. M., & Tervaert, J.-W. C. (2003) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2003.02157.x · Cited by 63
Bloch, D. A., Moses, L. E., & Michel, B. A. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330813 · Cited by 62 · cited 1×
“In fact, the referring rheumatologist’s diagnosis served as the gold standard in developing the ACR classification criteria, which have sensitivities ranging from 71% to 94% and specificities ranging from 87% to 92%.(27,28) Applying ACR criteria for WG, PAN, giant cell arteritis (GCA), and hypersensitivity vasculitis…”
BackgroundRecent advances in vascular inflammation: C-reactive protein and other inflammatory biomarkers
Maksimowicz‐McKinnon, K., Bhatt, D. L., & Calabrese, L. H. (2003) · Current Opinion in Rheumatology · doi:10.1097/00002281-200401000-00005 · Cited by 56
The effects of scleroderma serum on human microvascular endothelial cells
Marks, R. M., Czerniecki, M., Andrews, B. S., & Penny, R. (1988) · Arthritis & Rheumatism · doi:10.1002/art.1780311209 · Cited by 55
Endothelial cells, fibroblasts and vasculitis
Buckley, C. D., Rainger, G. E., Nash, G. B., & Raza, K. (2005) · Rheumatology · doi:10.1093/rheumatology/keh542 · Cited by 55
Brogan, P. A., Shah, V., Klein, N. J., & Dillon, M. J. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20021 · Cited by 50
Tissue Localization of Human Eosinophil Cationic Proteins in Allergic Diseases
Spry, C. J. F., Tai, P.-C., & Barkans, J. R. (2009) · International Archives of Allergy and Applied Immunology · doi:10.1159/000233803 · Cited by 48
Kaburagi, Y., Hasegawa, M., Nagaoka, T., Shimada, Y., Hamaguchi, Y., Komura, K., Saito, E., Yanaba, K., Takehara, K., Kadono, T., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.6.2970 · Cited by 45
Langford, C. A., & MHS (2003) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2003.80 · Cited by 44
Guida, E., & Stewart, A. (1998) · Cellular Physiology and Biochemistry · doi:10.1159/000016272 · Cited by 44
Inaloz, H. S., Evereklioğlu, C., Ünal, B., Kırtak, N., Eralp, A., & İnalöz, S. (2003) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2004.00547.x · Cited by 43 · cited 1×
“The skin prick test, used to initiate skin pathergy, induced endothelial expression of E-selectin, which recruits neutrophils, in Behc xet patients, but not in controls.(112) Persistent inflammation may play an important role in the development of ANCA, which can themselves amplify and maintain inflammation by activat…”
BackgroundEndothelial cell biology, perivascular inflammation, and vasculitis.
Cid, M. C. (2002) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.69.suppl_2.sii45 · Cited by 39
Chanseaud, Y., de la Peña-Lefebvre, P. G., Guilpain, P., Mahr, A., Tamby, M. C., Uzan, M., Guillevin, L., Boissier, M., & Mouthon, L. (2003) · Clinical Immunology · doi:10.1016/s1521-6616(03)00170-0 · Cited by 39 · cited 1×
“However, AECA are not suspected to be a primary factor in vasculitis as they are heterogeneous, mostly uncharacterized, and suspected to develop secondarily to inflammation and antigen modification.(43,153)”
BackgroundNew developments in the pathogenesis of ANCA-associated vasculitis.
Day, C., Hewins, P., & Savage, C. O. S. (2003) · PubMed · Cited by 36
Yanaba, K., Kaburagi, Y., Takehara, K., Steeber, D. A., Tedder, T. F., & Sato, S. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64279-4 · Cited by 36
Do vasculitis categorization systems really matter?
Jennette, J. C., & Falk, R. J. (2000) · Current Rheumatology Reports · doi:10.1007/s11926-000-0044-4 · Cited by 32 · cited 2×
“The diagnosis of vasculitis is a medical challenge due to the unknown or incompletely understood etiology and pathogenesis of most vasculitides as well as their protean and overlapping clinicopathologic features.(14,15) For instance, hepatitis C infection can be found in association with several different types of vas…”
BackgroundHypersensitivity vasculitis in adults: a benign disease usually limited to skin.
García-Porrúa, C., Llorca, J., González-Louzao, C., & González-Gay, M. Á. (2001) · PubMed · Cited by 26
Boom, B. W., Mommaas, M., Daha, M. R., & Vermeer, B. (1989) · Journal of Investigative Dermatology · doi:10.1038/jid.1989.12 · Cited by 25
Systemic small sized vessel vasculitis after massive antigen inhalation
Mouthon, L., KHALED, M., Cohen, P., Guillevin, L., MOUTHON, L., & Subra, J. (2001) · Annals of the Rheumatic Diseases · doi:10.1016/s0003-4967(24)43399-2 · Cited by 22 · cited 4×
“Type I Allergic or Anaphylactic Reactions Elevated IgE levels and both tissue and blood eosinophilia are found in patients with CSS.143–145 In the vasculitic phase of CSS, many cases do not show a classic necrotizing, neutrophilic vasculitis, but rather an angiocentric infiltration of vessel walls by eosinophils (Fig.”
BackgroundInfluentialLópez‐Hoyos, M., Bartolome-Pacheco, M. J., Blanco, R., Rodriguez-Valverde, V., & Martinez-Taboada, V. M. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.005900 · Cited by 22
Localized versus systemic vasculitis: Diagnosis and management
Quinet, R., Zakem, J., & McCain, M. (2003) · Current Rheumatology Reports · doi:10.1007/s11926-003-0036-2 · Cited by 19
Yanaba, K., Komura, K., Horikawa, M., Matsushita, Y., Takehara, K., & Sato, S. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.1203650 · Cited by 17
Dauchel, H., Joly, P., DELPECH, A., Thomine, E., SAUGER, E., Loët, X. L., LAURET, H., Tron, F., EONTAINE, M., & Ripoche, J. (1993) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1993.tb03392.x · Cited by 15
Is vasculitis a significant component of atherosclerosis?
Juvonen, T. S., Juvonen, J., & Savolainen, M. J. (1999) · Current Opinion in Rheumatology · doi:10.1097/00002281-199901000-00002 · Cited by 14 · cited 1×
“Vasculitis is an uncommon disorder as long as the inflammation found in atherosclerosis and ruptured plaques are not classified as vasculitis.(102) The annual incidence of biopsy-proven cutaneous vasculitis in Norwich, England was 39.”
BackgroundViac, J., Pernet, I., Schmitt, D., & Claudy, A. (1999) · Archives of Dermatological Research · doi:10.1007/s004030050464 · Cited by 13
Impaired neutrophil functions in patients with leukocytoclastic vasculitis
Grunwald, M. H., Shriker, O., Halevy, S., Alkan, M., & Levy, R. (1997) · International Journal of Dermatology · doi:10.1046/j.1365-4362.1997.00195.x · Cited by 9
Liu, Z., Yang, J., Chen, Z., Gong, R., & Leishi, L. (2001) · PubMed · Cited by 7
Pathophysiology of ischaemia-reperfusion injury
Carden, D. L., & Granger, D. N. (2000) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(200002)190:3 · Cited by 5
Cited by
Pattern Analysis of Drug-Induced Skin Diseases
Justiniano, H., Berlingeri-Ramos, A. C., & Sánchez, J. L. (2008) · The American Journal of Dermatopathology · doi:10.1097/dad.0b013e3181722ef4 · Cited by 86
“Vasculitis can be a primary idiopathic process, occurs secondarily to a systemic disease or occurs after an exposure to a foreign agent (infections, drugs, and preservatives).(188) When the vasculitic process affects only the skin, it is referred to as cutaneous leukocytoclastic angiitis.”
Background
Metadata
- Authors
- Carlson, J. A., Ng, B. T., & Chen, K.-R.
- Venue
- The American Journal of Dermatopathology
- Published
- 2005-12
- Volume
- 27
- Issue
- 6
- Pages
- 504-528
- ISSN
- 0193-1091 (ISSN-L)
- OpenAlex
- W2139147683
- Cited by
- 236
- References
- 111
- FWCI
- 10.11
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.